Product Information

VANCOMYCIN 1 GM VIAL is a generic product labeled by Hikma Pharmaceuticals USA Inc., priced at $2.9591 per EA under NDC 00143916210. Its NADAC has been published 53 times since Apr 17, 2024.

VANCOMYCIN 1 GM VIAL

vancomycin hydrochloride
$2.9591per EA

Strength

1025 mg/mg

NDC

00143916210

Classification

Generic

Dosage Form

INJECTION, POWDER, FOR SOLUTION

Route

INTRAVENOUS; ORAL

Last Updated

3/19/2025

Active Ingredients

VANCOMYCIN HYDROCHLORIDE

Approval Type

New Drug (NDA)

FDA Application

NDA210274

On Market Since

2/2/2023

Pharmacological Classes

Price Statistics

The NADAC for VANCOMYCIN 1 GM VIAL has been published 53 times since Apr 17, 2024, and over the history we have for it it has declined 5.2%. The table below summarizes its recorded NADAC range and movement.

Current price$2.9591 per EA
All-time high$3.3863 (Jul 10, 2024)
All-time low$2.5368 (Nov 20, 2024)
Median price$2.9591
Average price$2.9285
Largest weekly change-16.6% (Sep 18, 2024)
Weeks tracked53
Tracking sinceApr 17, 2024

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

0.0%

1Y

0.0%

3Y

N/A

5Y

N/A

All

-5.2%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the vancomycin hydrochloride market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.

Frequently asked questions

What is the NADAC price of VANCOMYCIN 1 GM VIAL?

The current National Average Drug Acquisition Cost (NADAC) for VANCOMYCIN 1 GM VIAL, manufactured by Hikma Pharmaceuticals USA Inc., is $2.9591 per EA (NDC 00143916210), effective Apr 16, 2025.

How has the price of VANCOMYCIN 1 GM VIAL changed over time?

Over the history we have for it, the NADAC for VANCOMYCIN 1 GM VIAL has declined 5.2%. It has been tracked across 53 weekly CMS publications since Apr 17, 2024.

What are the highest and lowest recorded NADAC prices for VANCOMYCIN 1 GM VIAL?

Since Apr 17, 2024, the NADAC for VANCOMYCIN 1 GM VIAL has ranged from a low of $2.5368 (Nov 20, 2024) to a high of $3.3863 (Jul 10, 2024), with a median of $2.9591 per EA.

Are there cheaper alternatives to VANCOMYCIN 1 GM VIAL?

No other NADAC-published product currently shares the active ingredient, strength, and dosage form of VANCOMYCIN 1 GM VIAL, so no direct lower-cost alternative is listed.

Who manufactures VANCOMYCIN 1 GM VIAL?

VANCOMYCIN 1 GM VIAL (NDC 00143916210) is labeled by Hikma Pharmaceuticals USA Inc., and CMS classifies it as a generic product.